PTGX

Protagonist Therapeutics Inc

1 day chart

About PTGX

Protagonist Therapeutics, Inc. is a biopharmaceutical company. The Company uses its peptide technology platform to discover and develop peptide-based drugs to address unmet medical needs. Its clinical programs address two categories of diseases, which includes hematology and blood disorders, and inflammatory and immunomodulatory diseases. Its lead clinical asset, rusfertide (PTG-300), is an injectable hepcidin mimetic in development for the treatment of erythrocytosis, iron overload and other blood disorders. The Company’s alpha-4-beta-7 (α4β7) antagonist PN-943 and its Interleukin-23 receptor (IL-23R) antagonist compound PN-235 are orally delivered investigational drugs that are designed to block biological pathways. PN-943 is an investigational, orally delivered, gut-restricted α4β7 specific integrin antagonist for inflammatory bowel disease (IBD). Its PN-235 is an orally delivered IL-23R specific antagonist for the treatment of IBD and non-IBD indications.

Buy US stocks in Australia starting with PTGX. Open an account and start investing today!

Market Capitalisation

$1.15B

Price-earnings ratio

Dividend yield

0.00%

Volume

319

High today

$22.38

Low today

$20.85

Open price

$0.00

52-week high

$25.76

52-week low

$6.91

PTGX FAQs

How much is one share of Protagonist Therapeutics Inc?

One share of Protagonist Therapeutics Inc is valued at $22.22.

What is the ticker symbol for Protagonist Therapeutics Inc?

The ticker symbol for Protagonist Therapeutics Inc is PTGX.

How do I buy PTGX shares in Australia?

To buy PTGX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in PTGX

What is the 52-week high for Protagonist Therapeutics Inc stock?

The Protagonist Therapeutics Inc 52-week high stock price is $25.76.

What is the 52-week low for Protagonist Therapeutics Inc stock?

The Protagonist Therapeutics Inc 52-week low stock price is $6.91.

What is the market capitalisation of Protagonist Therapeutics Inc PTGX?

As of 30/03/2023 Protagonist Therapeutics Inc has a market cap of $1.1B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.